What are the discharge precautions for a patient with herpes zoster (shingles)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Discharge precautions for a patient with herpes zoster (shingles) should prioritize preventing transmission of the varicella-zoster virus to susceptible individuals, especially pregnant women, newborns, and immunocompromised individuals, by avoiding direct contact and covering the rash completely until all lesions have crusted over, typically 7-10 days after rash onset. When managing a patient with shingles, it is crucial to consider the potential for transmission and the importance of antiviral therapy, as seen in a case where an 89-year-old man was prescribed acyclovir 800 mg orally five times daily for seven days and gabapentin 300 mg orally three times daily 1. Key precautions include:

  • Avoiding direct contact with people who have not had chickenpox or the chickenpox vaccine
  • Covering the rash completely with clothing or bandages
  • Washing hands frequently, especially after touching the affected areas
  • Avoiding scratching the rash to prevent secondary bacterial infections and further viral spread
  • Continuing antiviral medications as prescribed, such as acyclovir 800 mg five times daily
  • Managing pain with medications as directed, which may include acetaminophen, NSAIDs, or gabapentin for neuropathic pain, as in the case of the 89-year-old man who was prescribed gabapentin 300 mg orally three times daily 1. It is essential to keep the rash clean and dry and apply prescribed topical medications if recommended, all while emphasizing the importance of these precautions to prevent the transmission of the varicella-zoster virus to susceptible individuals.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Discharge Precautions for Herpes Zoster (Shingles)

  • The primary concern for discharge precautions is to prevent the spread of the varicella-zoster virus to susceptible individuals, such as children and immunocompromised patients 2.
  • Patients with herpes zoster should be advised to avoid contact with individuals who have not had chickenpox or have weakened immune systems until the rash has crusted over 3.
  • It is essential to educate patients on proper wound care and hygiene to prevent secondary bacterial infections 2.
  • Patients should be informed about the potential for postherpetic neuralgia and the importance of seeking medical attention if they experience persistent pain or other complications 4, 5.
  • Discharge instructions should include information on antiviral medication, pain management, and follow-up care to monitor for potential complications 4, 6.

Prevention of Herpes Zoster and Postherpetic Neuralgia

  • Vaccination is the most effective strategy for preventing herpes zoster and postherpetic neuralgia, and it is recommended for most adults 60 years and older 3, 6.
  • Antiviral therapy, such as acyclovir, famciclovir, or valacyclovir, can decrease the duration of the rash and may reduce the risk of postherpetic neuralgia 4, 5, 6.
  • Adjunct medications, including opioid analgesics, tricyclic antidepressants, or corticosteroids, may relieve the pain associated with acute herpes zoster 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Varicella and herpes zoster. Part 2: therapy and prevention].

Medizinische Klinik (Munich, Germany : 1983), 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.